Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2016

Filed with the SEC on May 23, 2016 and accepted by EDGAR at May 23, 2016, 16:27 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-01-01 to 2016-03-31$403.8kus-gaap:SalesRevenueNet
Cost of revenue3 months2016-01-01 to 2016-03-31$3.2kus-gaap:CostOfRevenue
Gross profit3 months2016-01-01 to 2016-03-31$400.6kus-gaap:GrossProfit
Operating income3 months2016-01-01 to 2016-03-31−$158.1kus-gaap:OperatingIncomeLoss
Interest expense3 months2016-01-01 to 2016-03-31−$84.3kus-gaap:InterestExpense
Net income3 months2016-01-01 to 2016-03-31−$238.9kus-gaap:NetIncomeLoss
Diluted EPS3 months2016-01-01 to 2016-03-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2016-01-01 to 2016-03-31−$285.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-03-31$24.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-03-31$725.1kus-gaap:AssetsCurrent
Total assetsAt period end2016-03-31$7.5mus-gaap:Assets
Current liabilitiesAt period end2016-03-31$2.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-03-31$6.1mus-gaap:Liabilities
Shareholders' equityAt period end2016-03-31$1.3mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001211524-16-000233. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.